Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Association study of polymorphism in leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes with phenotype of asthma and clinical parameters in Korean children

Leukotrienes C4 synthase와 cysteinyl leukotriene receptor 1 유전자 다형성과 한국 소아 천식 표현형 및 임상 지표와의 연관성 연구

  • Shim, Jung Yeon (Department of Pediatrics, Sungkyunkwan University School of Medicine) ;
  • Kim, Byung-Joo (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Song, Young Hwa (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Kang, Mi-Jin (Asan Institute for Life Science) ;
  • Lee, So-Yeon (Department of Pediatrics, University of Hallym College of Medicine) ;
  • Kim, Hyo-Bin (Department of Pediatrics, Inje University) ;
  • Yu, Jinho (Department of Pediatrics, University of Ulsan College of Medicine) ;
  • Hong, Soo-Jong (Department of Pediatrics, University of Ulsan College of Medicine)
  • 심정연 (성균관대학교 의과대학 소아과학교실) ;
  • 김병주 (울산대학교 의과대학 소아과학교실) ;
  • 송영화 (울산대학교 의과대학 소아과학교실) ;
  • 강미진 (아산 생명과학연구소) ;
  • 이소연 (한림대학교 의과대학 소아과학교실) ;
  • 김효빈 (인제대학교 의과대학 소아과학교실) ;
  • 유진호 (울산대학교 의과대학 소아과학교실) ;
  • 홍수종 (울산대학교 의과대학 소아과학교실)
  • Received : 2008.12.10
  • Accepted : 2009.05.22
  • Published : 2009.06.15
Download PDF
⟨ Previous Next ⟩

Abstract

Purpose : Cysteinyl leukotrienes are important proinflammatory mediators in asthma. Recently, it was suggested that a promoter polymorphism in the genes encoding for leukotriene C4 synthase (LTC4S), a key enzyme in the leukotriene synthetic pathway, and cysteinyl leukotriene receptor 1 (CysLTR1) might be associated with aspirin-intolerant asthma. We investigated whether polymorphisms in LTC4S and CysLTR1 genes or their interactions were associated with the asthma phenotype, lung function, or bronchial hyperreactivity (BHR) in Korean children. Methods : A total of 856 asthmatic children and 254 non-asthmatic controls were enrolled; a skin prick test, lung function test and bronchial provocation test were performed. Of those enrolled, 395 children underwent exercise challenge tests. The LTC4S A(-444)C and CysLTR1 T(＋927)C were genotyped by polymerase chain reaction-restriction fragment length polymorphism analysis. Results : Of those enrolled, 699 children were classified as having atopic asthma and 277 children, as having exercise-induced asthma (EIA). LTC4S and CysLTR1 polymorphisms were not associated with atopic asthma, EIA, or asthma per se. Lung function and BHR were not significantly different between the wild type (AA or TT) and the variant (AC＋CC or TC＋CC) genotypes in asthmatics, atopic asthmatics, and EIA (＋) asthmatics, while total eosinophil counts were higher in the variant type of LTC4S than in the wild type in atopic asthmatics. There were no associations between the gene-gene interactions of LTC4S and CysLTR1 genotypes and the asthma phenotypes. Conclusion : LTC4S A(-444)C and CysLTR1 T(＋927)C polymorphisms and their gene-gene interactions are not associated with asthma phenotype, lung function, or BHR in Korean children.

목 적 : 류코트리엔은 천식의 병태생리에 중요한 향염증성 매개체이며, 천식이나 운동유발성 천식에서 증가되어 있다. Leukotriene C4 synthase (LTC4S)의 A(-444)C 유전자 다형성과 cysteinyl leukotriene receptor 1 (CysLTR1) T(＋927)C 유전자 다형성이 한국 소아의 천식, 아토피 천식 및 운동유발성 천식과 연관이 있는지 알아보고, 폐기능, 기관지과민성, 총IgE 치에 영향을 미치는지 알아보고자 하였다. 방 법 : 총 856명의 천식 환자와 254명의 천식이 없는 정상아를 대상으로 하여 피부반응검사, 폐기능, 메타콜린 기관지 유발검사, 총 IgE 검사를 실시하였고, 천식 환자를 아토피 천식(699명), 운동유발성 천식(277명)으로 나누어 유전자 다형성과의 연관성을 조사하였다. LTC4S A9-444)C, CysLTR1 T(＋927)C 유전자형은 PCR-restriction fragment length polymorphism 방법으로 분석하였다. 결 과 : LTC4S A(-444)C 및 CysLTR1 T(＋927)C 유전자 다형성은 천식, 아토피 천식, 운동유발성 천식과의 연관성이 없었고, 폐기능, $PC_{20}$, 총IgE에도 차이를 보이지 않았다. 아토피 천식에서 총 호산구수는 변종형 LTC4S 유전자형에서 야생형 보다 높았다. LTC4S A(-444)C와 CysLTR1 T(＋927)C의 유전자-유전자 상호 작용도 천식, 아토피 천식, 운동유발성 천식과의 연관이 없었다. 결 론 : 한국 소아 천식의 표현형, 폐기능, 기관지과민성, 총IgE 농도는 LTC4S A(-444)C와 CysLTR1 T(＋927)C 유전자 다형성, 혹은 유전자-유전자 상호작용과 연관이 없는 것으로 생각된다.

Keywords

Acknowledgement

Supported by : Korean Pediatric Society

References

  1. Crowther SD, Rees PJ. Current treatment of asthma--focus on leukotrienes. Expert Opin Pharmacother 2000;1:1021-40 https://doi.org/10.1517/14656566.1.5.1021
  2. Sayers I, Barton S, Rorke S, Sawyer J, Peng Q, Beghe B, et al. Promoter polymorphism in the 5-lipoxygenase (ALOX5) and 5-lipoxygenase-activating protein (ALOX5AP) genes and asthma susceptibility in a Caucasian population. Clin Exp Allergy 2003;33:1103-10 https://doi.org/10.1046/j.1365-2222.2003.01733.x
  3. Bigby TD, Hodulik CR, Arden KC, Fu L. Molecular cloning of the human leukotriene C4 synthase gene and assignment to chromosome 5q35. Mol Med 1996;2:637-46
  4. Sanak M, Simon HU, Szczeklik A. Leukotriene C4 synthase promoter polymorphism and risk of aspirin-induced asthma. Lancet 1997;350:1599-600 https://doi.org/10.1016/S0140-6736(05)64015-9
  5. Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest 1998; 101:834-46 https://doi.org/10.1172/JCI620
  6. Sayers I, Barton S, Rorke S, Beghe B, Hayward B, Van Eerdewegh P, et al. Allelic association and functional studies of promoter polymorphism in the leukotriene C4 synthase gene (LTC4S) in asthma. Thorax 2003;58:417-24 https://doi.org/10.1136/thorax.58.5.417
  7. Van Sambeek R, Stevenson DD, Baldasaro M, Lam BK, Zhao J, Yoshida S, et al. 5' flanking region polymorphism of the gene encoding leukotriene C4 synthase does not correlate with the aspirin-intolerant asthma phenotype in the United States. J Allergy Clin Immunol 2000;106:72-6 https://doi.org/10.1067/mai.2000.107603
  8. Kim HB, Lee SY, Shim JY, Kim JH, Kang MJ, Hong SJ. The leukotriene C4 synthase (A-444C) promoter polymorphism is associated with the severity of exercise-induced asthma in Korean children. J Allergy Clin Immunol 2006;117: 1191-2 https://doi.org/10.1016/j.jaci.2005.12.1361
  9. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, Metters KM, et al. Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 1999;399:789-93 https://doi.org/10.1038/21658
  10. Choi JH, Park HS, Oh HB, Lee JH, Suh YJ, Park CS, et al. Leukotriene-related gene polymorphisms in ASA-intolerant asthma: an association with a haplotype of 5-lipoxygenase. Hum Genet 2004; 114:337-44 https://doi.org/10.1007/s00439-004-1082-1
  11. Lee SY, Kim HB, Kim JH, Kim BS, Kang MJ, Jang SO, et al. Responsiveness to montelukast is associated with bronchial hyperresponsiveness and total immunoglobulin E but not polymorphisms in the leukotriene C4 synthase and cysteinyl leukotriene receptor 1 genes in Korean children with exercise-induced asthma (EIA). Clin Exp Allergy 2007;37: 1487-93
  12. Hao L, Sayers I, Cakebread JA, Barton SJ, Beghe B, Holgate ST, et al. The cysteinyl-leukotriene type 1 receptor polymorphism 927T/C is associated with atopy severity but not with asthma. Clin Exp Allergy 2006;36:735-41 https://doi.org/10.1111/j.1365-2222.2006.02511.x
  13. Arriba-Mendez S, Sanz C, Isidoro-Garcia M, Davild I, Laffond E, Horeno E, et al. 927T>C polymorphism of the cysteinyl-leukotriene type-1 receptor (CYSLTR1) gene in children with asthma and atopic dermatitis. Pediatr Allergy Immunol 2006;17:323-8 https://doi.org/10.1111/j.1399-3038.2006.00416.x
  14. Sanz C, Isidro-Garcia M, Davila I, Moreno E, Laffond E, Lorente F. Analysis of 927T> C CYSLTRI and -444A > C LTC4S polymorphisms in patients with asthma. J Investig Allergol Clin Immunol 2006;16:331-7
  15. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. Am Rev Respir Dis 1987;136:225-44
  16. Joseph-Bowen J, de Klerk N, Holt PG, Sly PD. Relationship of asthma, atopy, and bronchial responsiveness to serum eosinophil cationic proteins in early childhood. J Allergy Clin Immunol 2004;114:1040-5 https://doi.org/10.1016/j.jaci.2004.07.051
  17. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, et al. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 2000;161: 309-29 https://doi.org/10.1164/ajrccm.161.1.ats11-99
  18. Garcia-Martin E. Interethnic and intraethnic variability of NAT2 single nucleotide polymorphisms. Curr Drug Metab 2008;9:487-97 https://doi.org/10.2174/138920008784892155
  19. Sampson AP, Siddiqui S, Buchanan D, Howarth PH, Holgate ST, Holloway JW, et al. Variant LTC(4) synthase allele modifies cysteinyl leukotriene synthesis in eosinophils and predicts clinical response to zafirlukast. Thorax 2000;55 Suppl 2:S28-31
  20. Acevedo N, Vergara C, Mercado D, Jiménez S, Caraballo L. The A-444C polymorphism of leukotriene C4 synthase gene is associated with IgE antibodies to Dermatophagoides pteronyssinus in a Colombian population. J Allergy Clin Immunol 2007;119:505-7 https://doi.org/10.1016/j.jaci.2006.10.002
  21. Kedda MA, Shi J, Duffy D, Phelps S, Yang I, O'Hara K, et al. Characterization of two polymorphisms in the leukotriene C4 synthase gene in an Australian population of subjects with mild, moderate, and severe asthma. J Allergy Clin Immunol 2004;113:889-95 https://doi.org/10.1016/j.jaci.2004.02.008
  22. Asano K, Shiomi T, Hasegawa N, Nakamura H, Kudo H, Matsuzaki T, et al. Leukotriene C4 synthase gene A(-444)C polymorphism and clinical response to a CYS-LT(1) antagonist, pranlukast, in Japanese patients with moderate asthma. Pharmacogenetics 2002;12:565-70 https://doi.org/10.1097/00008571-200210000-00009
  23. Zhang J, Migita O, Koga M, Shibasaki M, Arinami T, Noguchi E. Determination of structure and transcriptional regulation of CYSLTR1 and an association study with asthma and rhinitis. Pediatr Allergy Immunol 2006;17:242-9 https://doi.org/10.1111/j.1399-3038.2005.00347.x